Phosphoinositide 3-kinase and its targets in B-cell and T-cell signaling

Current Opinion in Immunology

Volumn 16, Issue 3, 2004, Pages 314-320

  Fruman, David A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

B cell receptor; BCR; Forkhead Box, Subgroup O; FOXO; glycogen synthase kinase 3; GSK 3; IKK ; IL; inhibitory NF B (I B) kinase ; interleukin; mammalian target of rapamycin; mTOR; NFAT; NF B; nuclear factor of activated T cells

Indexed keywords

CYTOKINE; LIPID; LYMPHOCYTE ANTIGEN RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOTRANSFERASE; PROTEIN KINASE B; PROTEIN SERINE KINASE; PROTEIN TYROSINE KINASE; THREONINE KINASE; UNCLASSIFIED DRUG;

B LYMPHOCYTE; CELL CYCLE; CELL FUNCTION; CELL SIZE; CELL SURVIVAL; ENZYME ACTIVATION; HUMAN; LYMPHOCYTE PROLIFERATION; MEDIATOR; METABOLIC ACTIVATION; NONHUMAN; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 2342667375     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2004.03.014     Document Type: Article

References (51)

1. Koyasu S. The role of PI3K in immune cells. Nat Immunol. 4:2003;313-319
2. Okkenhaug K., Vanhaesebroeck B. PI3K in lymphocyte development, differentiation and activation. Nat Rev Immunol. 3:2003;317-330
3. Deane JA, Fruman DA: Phosphoinositide 3-kinase: diverse roles in immune cell activation. Annu Rev Immunol 2004, in press.
4. Ohashi P.S. T-cell signalling and autoimmunity: molecular mechanisms of disease. Nat Rev Immunol. 2:2002;427-438
5. Kishimoto H., Hamada K., Saunders M., Backman S., Sasaki T., Nakano T., Mak T.W., Suzuki A. Physiological functions of pten in mouse tissues. Cell Struct Funct. 28:2003;11-21
6. Vanhaesebroeck B., Leevers S.J., Ahmadi K., Timms J., Katso R., Driscoll P.C., Woscholski R., Parker P.J., Waterfield M.D. Synthesis and function of 3-phosphorylated inositol lipids. Annu Rev Biochem. 70:2001;535-602
7. Donahue A.C., Fruman D.A. PI3K signaling controls cell fate at many points in B lymphocyte development and activation. Semin Cell Dev Biol. 15:2004;183-197
8. Fruman D.A., Satterthwaite A.B., Witte O.N. Xid-like phenotypes: a B cell signalosome takes shape. Immunity. 13:2000;1-3
9. Fluckiger A.C., Li Z., Kato R.M., Wahl M.I., Ochs H.D., Longnecker R., Kinet J.P., Witte O.N., Scharenberg A.M., Rawlings D.J. Btk/Tec kinases regulate sustained increases in intracellular Ca2+ following B-cell receptor activation. EMBO J. 17:1998;1973-1985
10. Scharenberg A.M., El-Hillal O., Fruman D.A., Beitz L.O., Li Z., Lin S., Gout I., Cantley L.C., Rawlings D.J., Kinet J.P. Phosphatidylinositol-3, 4, 5-trisphosphate (PtdIns-3, 4, 5-P3)/Tec kinase-dependent calcium signaling pathway: a target for SHIP-mediated inhibitory signals. EMBO J. 17:1998;1961-1972
11. Khan W.N., Alt F.W., Gerstein R.M., Malynn B.A., Larsson I., Rathbun G., Davidson L., Muller S., Kantor A.B., Herzenberg L.A., et al. Defective B cell development and function in Btk-deficient mice. Immunity. 3:1995;283-299
12. Satterthwaite A.B., Li Z., Witte O.N. Btk function in B cell development and response. Semin Immunol. 10:1998;309-316
13. Clayton E., Bardi G., Bell S.E., Chantry D., Downes C.P., Gray A., Humphries L.A., Rawlings D., Reynolds H., Vigorito E., et al. A crucial role for the p110delta subunit of phosphatidylinositol 3-kinase in B cell development and activation. J Exp Med. 196:2002;753-763
14. Jou S.T., Carpino N., Takahashi Y., Piekorz R., Chao J.R., Wang D., Ihle J.N. Essential, nonredundant role for the phosphoinositide 3-kinase p110delta in signaling by the B-cell receptor complex. Mol Cell Biol. 22:2002;8580-8591
15. Suzuki H., Matsuda S., Terauchi Y., Fujiwara M., Ohteki T., Asano T., Behrens T.W., Kouro T., Takatsu K., Kadowaki T., et al. PI3K and Btk differentially regulate B cell antigen receptor-mediated signal transduction. Nat Immunol. 4:2003;280-286 The authors demonstrate that PI3K activation is not required for the phosphorylation nor activation of Btk, and propose that PI3K and Btk function independently. The data might also be consistent with PI3K regulating a kinase-independent function of Btk at the membrane.
16. 2+ flux.
17. Leitges M., Schmedt C., Guinamard R., Davoust J., Schaal S., Stabel S., Tarakhovsky A. Immunodeficiency in protein kinase cbeta-deficient mice. Science. 273:1996;788-791
18. Glassford J., Soeiro I., Skarell S.M., Banerji L., Holman M., Klaus G.G., Kadowaki T., Koyasu S., Lam E.W. BCR targets cyclin D2 via Btk and the p85alpha subunit of PI3-K to induce cell cycle progression in primary mouse B cells. Oncogene. 22:2003;2248-2259
19. Forssell J., Nilsson A., Sideras P. Bruton's tyrosine-kinase-deficient murine B lymphocytes fail to enter S phase when stimulated with anti-immunoglobulin plus interleukin-4. Scand J Immunol. 49:1999;155-161
20. •] establish that PKCβ enhances NFκB activity by promoting IKKα phosphorylation.
21. Su T.T., Guo B., Kawakami Y., Sommer K., Chae K., Humphries L.A., Kato R.M., Kang S., Patrone L., Wall R., et al. PKC-beta controls I kappa B kinase lipid raft recruitment and activation in response to BCR signaling. Nat Immunol. 3:2002;780-786 The authors show that PKCβ enhances NFκB activity by promoting IKKα phosphorylation and recruitment to lipid rafts.
22. Grumont R.J., Strasser A., Gerondakis S. B cell growth is controlled by phosphatidylinosotol 3-kinase-dependent induction of Rel/NF-kappaB regulated c-myc transcription. Mol Cell. 10:2002;1283-1294 This paper shows that BCR-elicited cell-size increases are impaired in B cells lacking the NFκB components c-rel and NFκB1, or treated with PI3K inhibitors. This block in cell growth correlates with failure to upregulate the NFκB target gene c-myc.
23. Solvason N., Wu W.W., Kabra N., Lund-Johansen F., Roncarolo M.G., Behrens T.W., Grillot D.A., Nunez G., Lees E., Howard M. Transgene expression of bcl-xL permits anti-immunoglobulin (Ig)-induced proliferation in xid B cells. J Exp Med. 187:1998;1081-1091
24. 2+ mobilization.
25. Schaeffer E.M., Schwartzberg P.L. Tec family kinases in lymphocyte signaling and function. Curr Opin Immunol. 12:2000;282-288
26. Labno C.M., Lewis C.M., You D., Leung D.W., Takesono A., Kamberos N., Seth A., Finkelstein L.D., Rosen M.K., Schwartzberg P.L., et al. Itk functions to control actin polymerization at the immune synapse through localized activation of Cdc42 and WASP. Curr Biol. 13:2003;1619-1624
27. Grasis J.A., Browne C.D., Tsoukas C.D. Inducible T cell tyrosine kinase regulates actin-dependent cytoskeletal events induced by the T cell antigen receptor. J Immunol. 170:2003;3971-3976
28. Schwartzberg P.L. Amplifying Btk's signal. Immunity. 19:2003;634-636
29. Cantrell D. Protein kinase B (Akt) regulation and function in T lymphocytes. Semin Immunol. 14:2002;19-26
30. Vivanco I., Sawyers C.L. The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer. 2:2002;489-501
31. Otero D.C., Omori S.A., Rickert R.C. Cd19-dependent activation of Akt kinase in B-lymphocytes. J Biol Chem. 276:2001;1474-1478
32. Jones R.G., Parsons M., Bonnard M., Chan V.S., Yeh W.C., Woodgett J.R., Ohashi P.S. Protein kinase B regulates T lymphocyte survival, nuclear factor kappaB activation, and Bcl-X(L) levels in vivo. J Exp Med. 191:2000;1721-1734
33. Parsons M.J., Jones R.G., Tsao M.S., Odermatt B., Ohashi P.S., Woodgett J.R. Expression of active protein kinase B in T cells perturbs both T and B cell homeostasis and promotes inflammation. J Immunol. 167:2001;42-48
34. Rathmell J.C., Elstrom R.L., Cinalli R.M., Thompson C.B. Activated Akt promotes increased resting T cell size, CD28-independent T cell growth, and development of autoimmunity and lymphoma. Eur J Immunol. 33:2003;2223-2232 The authors study T cells expressing membrane-targeted Akt and report similar results to those in [32], but also show increased basal size and glycolytic rate.
35. Kane L.P., Andres P.G., Howland K.C., Abbas A.K., Weiss A. Akt provides the CD28 costimulatory signal for up-regulation of IL-2 and IFN-gamma but not TH2 cytokines. Nat Immunol. 2:2001;37-44
36. Kane L.P., Weiss A. The PI-3 kinase/Akt pathway and T cell activation: pleiotropic pathways downstream of PIP3. Immunol Rev. 192:2003;7-20
37. Ohteki T., Parsons M., Zakarian A., Jones R.G., Nguyen L.T., Woodgett J.R., Ohashi P.S. Negative regulation of T cell proliferation and interleukin 2 production by the serine threonine kinase GSK-3. J Exp Med. 192:2000;99-104
38. Wu L., Strasser A. 'Decisions, decisions.': beta-catenin-mediated activation of TCF-1 and Lef-1 influences the fate of developing T cells. Nat Immunol. 2:2001;823-824
39. Xu Y., Banerjee D., Huelsken J., Birchmeier W., Sen J.M. Deletion of beta-catenin impairs T cell development. Nat Immunol. 4:2003;1177-1182
40. Burgering B.M., Kops G.J. Cell cycle and death control: long live Forkheads. Trends Biochem Sci. 27:2002;352-360
41. Stahl M., Dijkers P.F., Kops G.J., Lens S.M., Coffer P.J., Burgering B.M., Medema R.H. The forkhead transcription factor FoxO regulates transcription of p27Kip1 and Bim in response to IL-2. J Immunol. 168:2002;5024-5031 The authors demonstrate that FOXO1 is phosphorylated following stimulation of human T cells with anti-CD3 plus IL-2, and that expression of a PI3K/Akt-independent FOXO3a promotes cell-cycle arrest and death in an IL-2-dependent T-cell line. This paper is the first to demonstrate a function for FOXO proteins in mature nontransformed lymphocytes.
42. Yusuf I, Zhu X, Kharas MG, Chen J, Fruman DA: Optimal B cell proliferation requires phosphoinositide 3-kinase-dependent inactivation of FOXO transcription factors. Blood 2004, in press.
43. Raught B., Gingras A.C., Sonenberg N. The target of rapamycin (TOR) proteins. Proc Natl Acad Sci USA. 98:2001;7037-7044
44. Storz P., Toker A. 3′-phosphoinositide-dependent kinase-1 (PDK-1) in PI 3-kinase signaling. Front Biosci. 7:2002;d886-d902
45. Manning B.D., Cantley L.C. Rheb fills a GAP between TSC and TOR. Trends Biochem Sci. 28:2003;573-576
46. Kane L.P., Mollenauer M.N., Xu Z., Turck C.W., Weiss A. Akt-dependent phosphorylation specifically regulates Cot induction of NF-kappa B-dependent transcription. Mol Cell Biol. 22:2002;5962-5974 The authors establish that the MAP3K family member Cot is a direct Akt substrate, and provide evidence that Cot links Akt to the NFκB pathway.
47. Yusuf I., Fruman D.A. Regulation of quiescence in lymphocytes. Trends Immunol. 24:2003;380-386
48. Donahue A.C., Fruman D.A. Proliferation and survival of activated B cells requires sustained antigen receptor engagement and phosphoinositide 3-kinase activation. J Immunol. 170:2003;5851-5860
49. 3 rapidly accumulates and is sustained at the site of T-cell contact with APC. In addition, the authors show that late addition of PI3K inhibitors blocks T-cell proliferation, indicating that sustained PI3K activation is likely to be functionally important.
50. •].
51. Niiro H., Clark E.A. Branches of the B cell antigen receptor pathway are directed by protein conduits Bam32 and Carma1. Immunity. 19:2003;637-640